These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 18164562

  • 1. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.
    Maturitas; 2008 Jan 20; 59(1):62-71. PubMed ID: 18164562
    [Abstract] [Full Text] [Related]

  • 2. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Creatsa MG, Economou EV, Siasou Z, Panoulis CP, Kalligerou I, Papadias C.
    Climacteric; 2008 Apr 15; 11(2):155-65. PubMed ID: 18365858
    [Abstract] [Full Text] [Related]

  • 4. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 5. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.
    Maturitas; 2006 Mar 20; 53(4):413-23. PubMed ID: 16140483
    [Abstract] [Full Text] [Related]

  • 6. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 20; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 7. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
    Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Vitoratos N, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
    Atherosclerosis; 2007 Jul 20; 193(1):142-50. PubMed ID: 16842799
    [Abstract] [Full Text] [Related]

  • 8. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 9. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    Eilertsen AL, Karssemeijer N, Skaane P, Qvigstad E, Sandset PM.
    BJOG; 2008 May 20; 115(6):773-9. PubMed ID: 18355366
    [Abstract] [Full Text] [Related]

  • 10. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis.
    Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM.
    Thromb Res; 2007 Jan 10; 120(3):371-9. PubMed ID: 17156824
    [Abstract] [Full Text] [Related]

  • 12. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 13. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA, TOTAL Study Investigators Group.
    BJOG; 2007 Dec 20; 114(12):1522-9. PubMed ID: 17995496
    [Abstract] [Full Text] [Related]

  • 14. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Stuedal A, Ma H, Bjørndal H, Ursin G.
    Climacteric; 2009 Jun 20; 12(3):248-58. PubMed ID: 19387884
    [Abstract] [Full Text] [Related]

  • 15. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H, Odabaşi AR, Demircan S, Karul A, Kozaci LD, Köseoğlu K, Kizilkaya K, Başak O.
    Gynecol Endocrinol; 2006 Jul 20; 22(7):381-7. PubMed ID: 16864148
    [Abstract] [Full Text] [Related]

  • 16. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 20; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 17. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM.
    Thromb Haemost; 2007 Jun 20; 97(6):938-43. PubMed ID: 17549295
    [Abstract] [Full Text] [Related]

  • 18. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
    Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, Bifulco G, Cirillo D, Guida M, Capasso R, Nappi C.
    Menopause; 2006 Jun 20; 13(4):660-8. PubMed ID: 16837888
    [Abstract] [Full Text] [Related]

  • 19. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B.
    Gynecol Endocrinol; 2005 Feb 20; 20(2):110-5. PubMed ID: 15823831
    [Abstract] [Full Text] [Related]

  • 20. Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation.
    Eilertsen AL, Qvigstad E, Andersen TO, Sandvik L, Sandset PM.
    Maturitas; 2006 Oct 20; 55(3):278-87. PubMed ID: 16713143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.